The estimated Net Worth of Genavent F.C.P.R. is at least 333 千$ dollars as of 7 May 2014. Genavent R owns over 10,000 units of Scynexis Inc stock worth over 332,637$ and over the last 11 years Genavent sold SCYX stock worth over 0$.
Genavent has made over 1 trades of the Scynexis Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Genavent bought 10,000 units of SCYX stock worth 100,000$ on 7 May 2014.
The largest trade Genavent's ever made was buying 10,000 units of Scynexis Inc stock on 7 May 2014 worth over 100,000$. On average, Genavent trades about 10,000 units every 0 days since 2014. As of 7 May 2014 Genavent still owns at least 237,598 units of Scynexis Inc stock.
You can see the complete history of Genavent R stock trades at the bottom of the page.
Genavent's mailing address filed with the SEC is 90 BOULEVARD PASTEUR, CS 21564, PARIS CEDEX 15, I0, 75730.
Over the last 10 years, insiders at Scynexis Inc have traded over 4,708,140$ worth of Scynexis Inc stock and bought 2,173,590 units worth 13,469,713$ . The most active insiders traders include Advisors Llcperceptive Life...、Patrick Machado、Marco Taglietti. On average, Scynexis Inc executives and independent directors trade stock every 49 days with the average trade being worth of 64,694$. The most recent stock trade was executed by Marco Taglietti on 26 April 2022, trading 75,000 units of SCYX stock currently worth 225,000$.
scynexis, inc. is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. our scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery and development of innovative medicines over a broad range of therapy areas. we are developing our lead product candidate, scy-078, a novel antifungal in phase 2, as a novel oral and intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.
Scynexis Inc executives and other stock owners filed with the SEC include: